These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 28851973)

  • 1. Frequency-dependent drug screening using optogenetic stimulation of human iPSC-derived cardiomyocytes.
    Lapp H; Bruegmann T; Malan D; Friedrichs S; Kilgus C; Heidsieck A; Sasse P
    Sci Rep; 2017 Aug; 7(1):9629. PubMed ID: 28851973
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequency-Dependent Multi-Well Cardiotoxicity Screening Enabled by Optogenetic Stimulation.
    Rehnelt S; Malan D; Juhasz K; Wolters B; Doerr L; Beckler M; Kettenhofen R; Bohlen H; Bruegmann T; Sasse P
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29211031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Proarrhythmic Potential of Drugs in Optogenetically Paced Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Patel D; Stohlman J; Dang Q; Strauss DG; Blinova K
    Toxicol Sci; 2019 Jul; 170(1):167-179. PubMed ID: 30912807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Electrical Stimulation on hiPSC-CM Responses to Classic Ion Channel Blockers.
    Wei F; Pourrier M; Strauss DG; Stockbridge N; Pang L
    Toxicol Sci; 2020 Apr; 174(2):254-265. PubMed ID: 32040191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chronic intermittent tachypacing by an optogenetic approach induces arrhythmia vulnerability in human engineered heart tissue.
    Lemme M; Braren I; Prondzynski M; Aksehirlioglu B; Ulmer BM; Schulze ML; Ismaili D; Meyer C; Hansen A; Christ T; Lemoine MD; Eschenhagen T
    Cardiovasc Res; 2020 Jul; 116(8):1487-1499. PubMed ID: 31598634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of Batch Variations in Induced Pluripotent Stem Cell-Derived Human Cardiomyocytes from 2 Major Suppliers.
    Huo J; Kamalakar A; Yang X; Word B; Stockbridge N; Lyn-Cook B; Pang L
    Toxicol Sci; 2017 Mar; 156(1):25-38. PubMed ID: 28031415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Multi-parametric assessment of cardiomyocyte excitation-contraction coupling using impedance and field potential recording: A tool for cardiac safety assessment.
    Zhang X; Guo L; Zeng H; White SL; Furniss M; Balasubramanian B; Lis E; Lagrutta A; Sannajust F; Zhao LL; Xi B; Wang X; Davis M; Abassi YA
    J Pharmacol Toxicol Methods; 2016; 81():201-16. PubMed ID: 27282640
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CSAHi study: Detection of drug-induced ion channel/receptor responses, QT prolongation, and arrhythmia using multi-electrode arrays in combination with human induced pluripotent stem cell-derived cardiomyocytes.
    Kitaguchi T; Moriyama Y; Taniguchi T; Maeda S; Ando H; Uda T; Otabe K; Oguchi M; Shimizu S; Saito H; Toratani A; Asayama M; Yamamoto W; Matsumoto E; Saji D; Ohnaka H; Miyamoto N
    J Pharmacol Toxicol Methods; 2017; 85():73-81. PubMed ID: 28163191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug-induced functional cardiotoxicity screening in stem cell-derived human and mouse cardiomyocytes: effects of reference compounds.
    Himmel HM
    J Pharmacol Toxicol Methods; 2013; 68(1):97-111. PubMed ID: 23702537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiotoxicity screening with simultaneous optogenetic pacing, voltage imaging and calcium imaging.
    Dempsey GT; Chaudhary KW; Atwater N; Nguyen C; Brown BS; McNeish JD; Cohen AE; Kralj JM
    J Pharmacol Toxicol Methods; 2016; 81():240-50. PubMed ID: 27184445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of extracellular field potential and Ca
    Abi-Gerges N; Pointon A; Oldman KL; Brown MR; Pilling MA; Sefton CE; Garside H; Pollard CE
    J Pharmacol Toxicol Methods; 2017; 83():1-15. PubMed ID: 27622857
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overexpression of KCNJ2 in induced pluripotent stem cell-derived cardiomyocytes for the assessment of QT-prolonging drugs.
    Li M; Kanda Y; Ashihara T; Sasano T; Nakai Y; Kodama M; Hayashi E; Sekino Y; Furukawa T; Kurokawa J
    J Pharmacol Sci; 2017 Jun; 134(2):75-85. PubMed ID: 28615142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models.
    Gruber A; Edri O; Glatstein S; Goldfracht I; Huber I; Arbel G; Gepstein A; Chorna S; Gepstein L
    J Am Heart Assoc; 2022 Feb; 11(4):e021615. PubMed ID: 35112880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiotoxicity screening of illicit drugs and new psychoactive substances (NPS) in human iPSC-derived cardiomyocytes using microelectrode array (MEA) recordings.
    Zwartsen A; de Korte T; Nacken P; de Lange DW; Westerink RHS; Hondebrink L
    J Mol Cell Cardiol; 2019 Nov; 136():102-112. PubMed ID: 31526813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of nefazodone-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes.
    Lee S; Lee HA; Choi SW; Kim SJ; Kim KS
    Toxicol Appl Pharmacol; 2016 Apr; 296():42-53. PubMed ID: 26821276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Electrophysiological characteristics and pharmacological sensitivity of two lines of human induced pluripotent stem cell derived cardiomyocytes coming from two different suppliers.
    Goineau S; Castagné V
    J Pharmacol Toxicol Methods; 2018; 90():58-66. PubMed ID: 29274391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proarrhythmia Risk Assessment in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes Using the Maestro MEA Platform.
    Qu Y; Vargas HM
    Toxicol Sci; 2015 Sep; 147(1):286-95. PubMed ID: 26117837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of acquisition and analysis methods in multi-electrode array experiments with iPS cell-derived cardiomyocytes.
    Asakura K; Hayashi S; Ojima A; Taniguchi T; Miyamoto N; Nakamori C; Nagasawa C; Kitamura T; Osada T; Honda Y; Kasai C; Ando H; Kanda Y; Sekino Y; Sawada K
    J Pharmacol Toxicol Methods; 2015; 75():17-26. PubMed ID: 25910965
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiac safety assessment with motion field imaging analysis of human iPS cell-derived cardiomyocytes is improved by an integrated evaluation with cardiac ion channel profiling.
    Isobe T; Honda M; Komatsu R; Tabo M
    J Toxicol Sci; 2019; 44(12):859-870. PubMed ID: 31813905
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulating cardiac physiology in engineered heart tissue with the bidirectional optogenetic tool BiPOLES.
    Schwarzová B; Stüdemann T; Sönmez M; Rössinger J; Pan B; Eschenhagen T; Stenzig J; Wiegert JS; Christ T; Weinberger F
    Pflugers Arch; 2023 Dec; 475(12):1463-1477. PubMed ID: 37863976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.